Facing the Omicron variant – How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, Madeleine Batke, Léa-Sophie Dreveton, Brogan Geurts, Judith Koch, Stefan Köppe, Marina Treskova, Sabine Vygen-Bonnet, Maria Waize, Ole Wichmann, Thomas Harder
doi: https://doi.org/10.1101/2022.05.25.22275516
Wiebe Külper-Schiek
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Vanessa Piechotta
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Antonia Pilic
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Madeleine Batke
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Léa-Sophie Dreveton
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Brogan Geurts
2Centre for International Health Protection, Robert Koch Institute, Berlin, Germany
Judith Koch
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Stefan Köppe
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Marina Treskova
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
3Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany
Sabine Vygen-Bonnet
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Maria Waize
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Ole Wichmann
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Thomas Harder
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Posted May 27, 2022.
Facing the Omicron variant – How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, Madeleine Batke, Léa-Sophie Dreveton, Brogan Geurts, Judith Koch, Stefan Köppe, Marina Treskova, Sabine Vygen-Bonnet, Maria Waize, Ole Wichmann, Thomas Harder
medRxiv 2022.05.25.22275516; doi: https://doi.org/10.1101/2022.05.25.22275516
Facing the Omicron variant – How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, Madeleine Batke, Léa-Sophie Dreveton, Brogan Geurts, Judith Koch, Stefan Köppe, Marina Treskova, Sabine Vygen-Bonnet, Maria Waize, Ole Wichmann, Thomas Harder
medRxiv 2022.05.25.22275516; doi: https://doi.org/10.1101/2022.05.25.22275516
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12764)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4598)
- Geriatric Medicine (420)
- Health Economics (730)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4373)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1532)
- Respiratory Medicine (915)
- Rheumatology (440)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)